Lunai Bioworks (LNAI) Total Debt Growth (1y) (2012 - 2022)
Lunai Bioworks (LNAI) Total Debt Growth (1y) (2012 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lunai Bioworks |
95.85 Mn |
92.70 Mn |
20,942.00 |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
-0.03% |
| Jun 30, 2022 |
-0.04% |
| Sep 30, 2021 |
-37.20% |
| Jun 30, 2021 |
-41.02% |
| Mar 31, 2021 |
14.47% |
| Dec 31, 2020 |
57.47% |
| Sep 30, 2020 |
37.24% |
| Jun 30, 2020 |
36.99% |
| Mar 31, 2020 |
-72.65% |
| Dec 31, 2019 |
-81.71% |
| Sep 30, 2019 |
-74.80% |
| Jun 30, 2019 |
-75.24% |
| Dec 31, 2013 |
-95.42% |
| Sep 30, 2013 |
0.00% |
| Mar 31, 2013 |
71.96% |
| Dec 31, 2012 |
4,739.11% |
| Sep 30, 2012 |
178.38% |
| Mar 31, 2012 |
154.55% |
